Gymnema sylvestre leaf extract,
does it really help with Reduction of blood glucose and sugar cravings?
research showsBlood glucose shows improvement signals in small RCTs and a meta-analysis, but the meta-analysis relied on before-after comparisons rather than controls and heterogeneity was 80-99%. Sugar craving decreased in some short mint trials, but free-living intake results conflict.
ads claimDescriptions may claim sugar blocking, elimination of sugar desire, or normalization of blood glucose. Temporary taste-receptor blockade and long-term glycemic control are different claims.
Useful facts when choosing a product
- One glycemic RCT formulation used 600 mg/day.
- Sweet-taste suppression from a mint is a sensory effect lasting about 30-60 minutes.
- Hypoglycemia is possible with glucose-lowering drugs.
- A case of Gymnema-associated liver injury has been reported.
What the research actually shows
Devangan 2021 pooled 10 studies and 419 participants, but before-after analysis and I² of 80-99% were limitations. Zúñiga 2020 reported improved OGTT and HbA1c after 600 mg/day in a 30-person RCT. In the Turner 2022 trial of 58 participants, chocolate intake fell only on day zero and food-category intake did not differ after 14 days. Hsiao 2025 reported some craving and beverage outcomes in 32 participants.
Why this is classified as C (44)
Surrogate outcomes, before-after comparisons, high heterogeneity, and short conflicting craving results lead to C with 43 points.
Counterpoint. Short-term signals from a particular standardized extract or mint remain, but they do not establish long-term clinical effects.
Rejudgment record. New judgment — Surrogate outcomes, before-after comparisons, high heterogeneity, and short conflicting craving results lead to C with 43 points.
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Blood-glucose reduction | C | Small positive RCTs exist, but the meta-analysis used before-after comparisons with high heterogeneity. |
| Reduction of sugar cravings | C | Short mint trials conflict and changes in actual intake are limited. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Devangan S et al. 2021 | Systematic review and meta-analysis | 419 | Unknown | FPG, PPBG, and HbA1c | Reported reductions; I² 80-99%, mainly baseline comparisons. | Key |
| Zúñiga LY et al. 2020 | Double-blind placebo-controlled RCT | 30 | Unknown | Two-hour OGTT and HbA1c | Reported improvement with 600 mg/day. | Supportive |
| Turner S et al. 2022 | Randomized placebo-controlled trial | 58 | Nu Brands Inc | Craving, chocolate, and food intake | Laboratory signal on day zero, but no actual-intake difference after 14 days. | Key |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-11).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Gymnema sylvestre leaf extract x Reduction of blood glucose and sugar cravings — Evidence Grade C·44. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/blood-sugar/gymnema-blood-sugar-cravings/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.